<DOC>
	<DOC>NCT01145677</DOC>
	<brief_summary>This is a 12-Week, randomized controlled study of topiramate in hospitalized patients with alcoholism</brief_summary>
	<brief_title>Efficacy of Topiramate for Hospitalized Patients With Alcoholism</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>patients hospitalized due to alcoholrelated problem DSMIVTR alcohol dependence for male: history of alcohol drink &gt;=35/week, female: history of alcohol drink &gt;=28/week for at least 1 week during four weeks prior to the admission AUDIT score at least 8 mild or no alcohol withdrawal symptom BMI &gt; 18 kg/m2 not pregnant and no plan for pregnancy intention to decrease or stop drinking severe psychiatric and cognitive disorders other substance dependence, except nicotine and caffeine dependence, during 6 months prior to enrollment taking antipsychotics, mood stabilizers, anticonvulsants, opioid analgesics, systemic steroids, carbonic anhydrase inhibitors, hydrochlorthiazide, metformin, pioglitazone, or disulfiram unstable medical condition medical history of narrow angle glaucoma, renal impairment, kidney stones, and seizures moderate to high risk of suicide under legal process plan to receive a formal treatment for alcoholism from other treatment settings pregnancy and nursing woman abnormal laboratory tests, including blood urea nitrogen, creatinine, electrolytes, and fasting blood sugar</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Alcohol dependence</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Topiramate</keyword>
</DOC>